These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16042308)

  • 1. Hematopoietic cell transplantation ameliorates clinical phenotype and progression of the CNS pathology in the mouse model of late onset Krabbe disease.
    Yagi T; Matsuda J; Tominaga K; Suzuki K; Suzuki K
    J Neuropathol Exp Neurol; 2005 Jul; 64(7):565-75. PubMed ID: 16042308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic ablation of Saposin-D in Krabbe disease eliminates psychosine accumulation but does not significantly improve demyelination.
    Watanabe T; Tsuboi K; Matsuda N; Ishizuka Y; Go S; Watanabe E; Ono A; Okamoto Y; Matsuda J
    J Neurochem; 2023 Aug; 166(4):720-746. PubMed ID: 37337846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic phenotypic improvement during pregnancy in a genetic leukodystrophy: estrogen appears to be a critical factor.
    Matsuda J; Vanier MT; Saito Y; Suzuki K; Suzuki K
    Hum Mol Genet; 2001 Nov; 10(23):2709-15. PubMed ID: 11726558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
    Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
    Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinico-pathological study of saposin-A-deficient (SAP-A-/-) and Twitcher mice.
    Yagi T; Matsuda J; Takikita S; Mohri I; Suzuki K; Suzuki K
    J Neuropathol Exp Neurol; 2004 Jul; 63(7):721-34. PubMed ID: 15290897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The twitcher mouse: a model for Krabbe disease and for experimental therapies.
    Suzuki K; Suzuki K
    Brain Pathol; 1995 Jul; 5(3):249-58. PubMed ID: 8520724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
    Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
    Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy.
    Reddy AS; Kim JH; Hawkins-Salsbury JA; Macauley SL; Tracy ET; Vogler CA; Han X; Song SK; Wozniak DF; Fowler SC; Klein RS; Sands MS
    J Neurosci; 2011 Jul; 31(27):9945-57. PubMed ID: 21734286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system-directed AAV2/5-mediated gene therapy synergizes with bone marrow transplantation in the murine model of globoid-cell leukodystrophy.
    Lin D; Donsante A; Macauley S; Levy B; Vogler C; Sands MS
    Mol Ther; 2007 Jan; 15(1):44-52. PubMed ID: 17164774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides.
    Ichioka T; Kishimoto Y; Brennan S; Santos GW; Yeager AM
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4259-63. PubMed ID: 2884662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 deficiency allows for enhanced therapeutic value after bone marrow transplantation across a minor histocompatibility barrier in the twitcher (globoid cell leukodystrophy) mouse.
    Biswas S; Pinson DM; Bronshteyn IG; LeVine SM
    J Neurosci Res; 2001 Aug; 65(4):298-307. PubMed ID: 11494365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
    Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
    J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements.
    Shen JS; Watabe K; Ohashi T; Eto Y
    Gene Ther; 2001 Jul; 8(14):1081-7. PubMed ID: 11526455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the Pathogenesis and Treatment of Krabbe Disease.
    Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
    Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
    Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Globoid cell leukodystrophy (Krabbe's disease): update.
    Suzuki K
    J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral neuropathy in the twitcher mouse: accumulation of extracellular matrix in the endoneurium and aberrant expression of ion channels.
    Kagitani-Shimono K; Mohri I; Yagi T; Taniike M; Suzuki K
    Acta Neuropathol; 2008 May; 115(5):577-87. PubMed ID: 18172657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice.
    Rafi MA; Rao HZ; Luzi P; Wenger DA
    Mol Ther; 2015 Nov; 23(11):1681-1690. PubMed ID: 26329589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare Saposin A deficiency: Novel variant and psychosine analysis.
    Calderwood L; Wenger DA; Matern D; Dahmoush H; Watiker V; Lee C
    Mol Genet Metab; 2020 Feb; 129(2):161-164. PubMed ID: 31439510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-reduction therapy enhances the benefits of bone marrow transplantation in young mice with globoid cell leukodystrophy.
    Biswas S; LeVine SM
    Pediatr Res; 2002 Jan; 51(1):40-7. PubMed ID: 11756638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.